News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
159,175 Results
Type
Article (7257)
Company Profile (13)
Press Release (151905)
Multimedia
Podcasts (15)
Webinars (6)
Section
Business (56143)
Career Advice (368)
Deals (10470)
Drug Delivery (17)
Drug Development (15794)
Employer Resources (29)
FDA (3033)
Job Trends (2443)
News (85921)
Policy (6930)
Tag
2027 Genetown Elite (1)
2027 Pharm Country Standard (1)
Academia (344)
Accelerated approval (6)
Adcomms (1)
Allergies (30)
Alliances (12332)
ALS (29)
Alzheimer's disease (306)
Antibody-drug conjugate (ADC) (105)
Approvals (3135)
Artificial intelligence (91)
Autoimmune disease (38)
Automation (6)
Bankruptcy (71)
Best Places to Work (1919)
BIOSECURE Act (2)
Biosimilars (74)
Biotechnology (16)
Bladder cancer (35)
Brain cancer (8)
Breast cancer (115)
Cancer (937)
Cardiovascular disease (40)
Career advice (330)
Career pathing (4)
CAR-T (47)
CDC (8)
Cell therapy (146)
Cervical cancer (6)
Clinical research (13834)
Collaboration (432)
Company closure (1)
Compensation (68)
Complete response letters (11)
COVID-19 (508)
CRISPR (5)
C-suite (370)
Cystic fibrosis (34)
Data (1149)
Denatured (2)
Depression (26)
Diabetes (100)
Diagnostics (1323)
Digital health (10)
Diversity, equity & inclusion (10)
Drug discovery (72)
Drug pricing (22)
Drug shortages (5)
Duchenne muscular dystrophy (95)
Earnings (23807)
Editorial (17)
Employer branding (1)
Employer resources (27)
Events (17667)
Executive appointments (460)
FDA (3754)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (1)
Funding (348)
Gene editing (27)
Generative AI (6)
Gene therapy (122)
GLP-1 (190)
Government (775)
Grass and pollen (2)
Guidances (110)
Healthcare (3780)
HIV (5)
Huntington's disease (9)
IgA nephropathy (27)
Immunology and inflammation (38)
Immuno-oncology (14)
Indications (20)
Infectious disease (561)
Inflammatory bowel disease (51)
Inflation Reduction Act (2)
Influenza (25)
Intellectual property (85)
Interviews (44)
IPO (4279)
IRA (8)
Job creations (562)
Job search strategy (286)
JPM (7)
Kidney cancer (3)
Labor market (13)
Layoffs (75)
Leadership (7)
Legal (1829)
Liver cancer (25)
Longevity (3)
Lung cancer (137)
Lymphoma (62)
Machine learning (6)
Management (7)
Manufacturing (179)
MASH (41)
Medical device (3089)
Medtech (3109)
Mergers & acquisitions (6603)
Metabolic disorders (235)
Multiple sclerosis (35)
NASH (3)
Neurodegenerative disease (62)
Neuropsychiatric disorders (19)
Neuroscience (569)
NextGen: Class of 2026 (1116)
Non-profit (476)
Now hiring (4)
Obesity (94)
Opinion (67)
Ovarian cancer (42)
Pain (46)
Pancreatic cancer (33)
Parkinson's disease (62)
Partnered (5)
Patents (132)
Patient recruitment (105)
Peanut (6)
People (20371)
Pharmaceutical (10)
Pharmacy benefit managers (10)
Phase 1 (4135)
Phase 2 (6177)
Phase 3 (4928)
Pipeline (1303)
Policy (47)
Postmarket research (377)
Preclinical (1474)
Press Release (18)
Prostate cancer (41)
Psychedelics (9)
Radiopharmaceuticals (85)
Rare diseases (184)
Real estate (1074)
Recruiting (15)
Regulatory (5331)
Reports (17)
Research institute (362)
Resumes & cover letters (44)
Rett syndrome (3)
RNA editing (3)
RSV (10)
Schizophrenia (51)
Series A (77)
Series B (47)
Service/supplier (1)
Sickle cell disease (17)
Special edition (3)
Spinal muscular atrophy (24)
Sponsored (10)
Startups (888)
State (1)
Stomach cancer (2)
Supply chain (28)
Tariffs (7)
The Weekly (13)
Vaccines (153)
Venture capital (22)
Weight loss (51)
Women's health (13)
Worklife (2)
Date
Last 7 days (125)
Last 30 days (513)
Last 365 days (6892)
2026 (692)
2025 (6956)
2024 (8513)
2023 (9562)
2022 (14295)
2021 (14136)
2020 (12946)
2019 (9475)
2018 (7366)
2017 (7675)
2016 (7070)
2015 (8518)
2014 (6439)
2013 (5143)
2012 (5527)
2011 (5794)
2010 (5284)
Location
Africa (180)
Alabama (15)
Alaska (2)
Arizona (55)
Arkansas (4)
Asia (25393)
Australia (3051)
California (2116)
Canada (938)
China (481)
Colorado (104)
Connecticut (102)
Delaware (54)
Europe (25293)
Florida (306)
Georgia (73)
Idaho (6)
Illinois (159)
India (39)
Indiana (120)
Japan (272)
Kansas (16)
Kentucky (3)
Louisiana (3)
Maine (10)
Maryland (317)
Massachusetts (1490)
Michigan (35)
Minnesota (100)
Missouri (13)
Montana (13)
Nebraska (8)
Nevada (22)
New Hampshire (22)
New Jersey (955)
New Mexico (7)
New York (582)
North Carolina (356)
Northern California (994)
Ohio (49)
Oklahoma (4)
Oregon (3)
Pennsylvania (399)
Puerto Rico (9)
Rhode Island (9)
South America (256)
South Carolina (4)
Southern California (873)
Tennessee (16)
Texas (315)
United States (7862)
Utah (61)
Virginia (64)
Washington D.C. (12)
Washington State (117)
West Virginia (1)
Wisconsin (21)
Wyoming (1)
159,175 Results for "acino holding ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Faron Pharmaceuticals Ltd: Holding(s) in Company
December 5, 2025
·
3 min read
Allecra Therapeutics and Acino Sign Exclusive Licensing and Supply Agreement for Allecra’s Novel Antibiotic EXBLIFEP® in Gulf Cooperation Council countries and South Africa
Allecra Therapeutics and Acino announced the signing of an exclusive licensing agreement under which Acino gains the rights to commercialise Allecra’s antibiotic drug EXBLIFEP® within the Republic of South Africa and the member states of the GCC alliance, which includes Bahrain, Kuwait, Oman, Qatar, Saudi Arabia, and the United Arab Emirates, effective from 12 June 2024.
June 24, 2024
·
5 min read
Press Releases
QureBio Ltd. to Present at ASCO 2026 its Q-1802 Phase II Clinical Results
January 29, 2026
·
3 min read
Press Releases
Cellyan Biotechnology Co., Ltd Receives Nasdaq Notice of Bid Price Deficiency
January 19, 2026
·
4 min read
Press Releases
Faron Pharmaceuticals Ltd: Appointment of CFO
December 1, 2025
·
3 min read
Business
SERB Pharmaceuticals grants exclusive license to M8 Pharmaceuticals, an Acino company, to bring Voraxaze® (Glucarpidase) to cancer patients in Latin America
SERB Pharmaceuticals (“SERB”), a global specialty pharmaceutical company, and M8 Pharmaceuticals, an Acino company (“M8”) are collaborating to bring an important drug for cancer patients to Latin America.
March 20, 2024
·
6 min read
Gene editing
FDA Lifts One of Two Clinical Holds on Intellia’s ATTR Gene Editing Program
After a patient safety signal and then death, the FDA in October 2025 placed holds on two of the company’s CRISPR programs for hereditary transthyretin amyloidosis.
January 27, 2026
·
2 min read
·
Dan Samorodnitsky
Press Releases
YD Bio Limited Enters into Binding Letter of Intent to Acquire Safe Save Medical Cell Sciences & Technology Co., Ltd., Bolstering Leadership in Advanced Immunocell Therapy
January 29, 2026
·
6 min read
Press Releases
vTv Therapeutics Amends License Agreement with Newsoara Biopharma Co. Ltd. for PDE4 inhibitor, HPP737
February 2, 2026
·
7 min read
Press Releases
Ayrmid Pharma Ltd Announces Additional Positive Results for Omisirge(R) in Treating Severe Aplastic Anemia (SAA) Presented at TANDEM
February 5, 2026
·
4 min read
1 of 15,918
Next
